Oral supplementation of trans‐cinnamaldehyde reduces uropathogenic Escherichia coli colonization in a mouse model

Urinary tract infections (UTIs) in the United States result in more than 7 million hospital visits per year. Uropathogenic Escherichia coli (UPEC) is responsible for more than 80% of UTIs. Although antibiotics are the drug of choice to control UTIs, their repeated use has resulted in the emergence o...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Letters in applied microbiology 2017-03, Vol.64 (3), p.192-197
Hauptverfasser:	Narayanan, A., Muyyarikkandy, M.S., Mooyottu, S., Venkitanarayanan, K., Amalaradjou, M.A.R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Acrolein - administration & dosage Acrolein - analogs & derivatives Acrolein - chemistry Animals Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - chemistry Antibiotics Berries Bladder Disease Models, Animal Drug resistance E coli Escherichia coli Escherichia coli Infections - drug therapy Escherichia coli Infections - microbiology Female Humans lower urinary tract infections Mice Mice, Inbred C57BL transurethral catheterization trans‐cinnamaldehyde Urinary tract infections Urinary Tract Infections - drug therapy Urinary Tract Infections - microbiology Urogenital system uropathogenic Escherichia coli Uropathogenic Escherichia coli - drug effects Uropathogenic Escherichia coli - growth & development
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!